The overexpression of EPHB2 mediated by tRF-1:28-Val-CAC-2 in NPC cells was ultimately found to drive their malignant growth, providing a promising new avenue for efforts to diagnose and treat this deadly disease. The gene discussed is EPHB2; the disease is nasopharyngeal carcinoma.